DIA Biosimilars 2013

CROs/Service Providers

Charles River opens new biomedical diagnostic facility

Friday, September 7, 2012 12:30 PM

Charles River Laboratories, a global preclinical CRO, has opened its new biomedical diagnostic testing facility in Wilmington, Mass.

More... »

Cenduit: Now with Patient Reminders

Marken opens two pharmaceutical depots in New York and Germany

Wednesday, September 5, 2012 11:02 AM

Marken, a global clinical supply chain solutions provider, has completed the first phase of its plan to create a global pharmaceutical depot network that will allow it to satisfy its client's needs for global distribution. Two new depots have been completed: one in Frankfurt, Germany, and one in Farmingdale, New York.

More... »

CRF Health – eCOA Forum

CLC bio acquires Molegro

Wednesday, September 5, 2012 10:55 AM

CLC bio, a provider of bioinformatics solutions, has acquired Molegro, a specialized software company focusing on molecular docking, including prediction and analysis of protein-ligand interactions, screening of compound databases for activities against a receptor and determination of molecule similarity.

More... »

Icon forms partnership with University College Dublin

Wednesday, September 5, 2012 10:13 AM

Icon,a global provider of outsourced development services, has entered into a strategic partnership with University College Dublin (UCD), Ireland’s largest third-level institution.

More... »

Hospira to acquire API manufacturing and R&D facilities in India

Thursday, August 30, 2012 11:22 AM

Hospira, a global provider of injectable drugs and infusion technologies, has agreed to acquire an active pharmaceutical ingredient (API) manufacturing facility, together with an associated R&D facility, from Orchid Chemicals & Pharmaceuticals of India for approximately $200 million.

More... »

QED Clinical Services to launch OrphanReach drug development division

Thursday, August 30, 2012 11:13 AM

QED Clinical Services, a global niche CRO operating, is launching OrphanReach, a division to develop drugs in rare disease areas.

More... »

Charles River acquires Accugenix

Thursday, August 30, 2012 10:35 AM

Charles River Laboratories International, a global provider of research products and services, has acquired Accugenix, a global provider of cGMP-compliant contract microbial identification testing, for approximately $17 million in cash.

More... »

Hospira to expand operations, create 200 jobs

Wednesday, August 29, 2012 11:20 AM

Hospira, a provider of injectable medicines and infusion technologies, is modernizing and expanding the capabilities of its operations in Nash County of N.C.

More... »

Medtronic establishes Shanghai Innovation Center

Wednesday, August 29, 2012 10:54 AM

Medtronic, a global medical technology company based in Minneapolis, Minn., has officially opened its Innovation Center in Shanghai, China.

More... »

QPS acquires JSW Life Sciences

Wednesday, August 29, 2012 09:47 AM

QPS, a global full-service GLP/GCP-compliant CRO based in Newark, Del., has acquired a majority interest in JSW Life Sciences, a provider of preclinical and clinical phase II-IV drug development services. The company will be known as QPS JSW.

More... »

CenterWatch Drugs in Clinical Trials Database Library. Drug intelligence right at your fingertips.
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs